[16 August 2022] SK bioscience announced that Tae Won Chey, Chairman of SK group, Chang Won (Andr...

SK extends the vaccination age of Nuvaxovid to 12 to 17-year-oldsThe recombinant protein-based vacci...

SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Health Organiz...

If approved, SK bioscience will accelerate to apply for emergency use listing (EUL) to the World Hea...

SK bioscience and Novavax agreement also includes production of the Novavax COVID-19 vaccine in pre...

Neutralizing antibody titres against Omicron variant BA.1 after a booster dose of SKYCovione™ were ...

SKYCovione™ will be ready to enter into domestic vaccine markets after passing the national lot rel...

· SK bioscience held the Global Forum to discuss about the Next Pandemic response strategy throug...

Trevor Mundel, President of the Global Health Division of the Bill & Melinda Gates Foundation(c...

Recombinant protein-based ‘GBP510’ with GSK pandemic adjuvant demonstrates superior neutralising tit...